HOOKIPA Pharma Inc
We are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body's immune system.
$14.00 - $16.00
April 18, 2019
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, LEERINK SWANN & COMPANY, RBC CAPITAL MARKETS CORPORATION
To view the prospectus for HOOKIPA Pharma Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277